Compare WYETH with Suven Life Sciences - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs SUVEN LIFE SCIENCES - Comparison Results

WYETH     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH SUVEN LIFE SCIENCES WYETH/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 27.7 -82.7 - View Chart
P/BV x 5.3 1.3 412.4% View Chart
Dividend Yield % 1.3 1.8 71.9%  

Financials

 WYETH   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    WYETH
Mar-13
SUVEN LIFE SCIENCES
Mar-19
WYETH/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,044338 309.3%   
Low Rs818169 482.9%   
Sales per share (Unadj.) Rs298.652.1 572.7%  
Earnings per share (Unadj.) Rs57.26.8 838.0%  
Cash flow per share (Unadj.) Rs58.48.6 681.6%  
Dividends per share (Unadj.) Rs17.001.50 1,133.3%  
Dividend yield (eoy) %1.80.6 308.6%  
Book value per share (Unadj.) Rs249.565.3 382.1%  
Shares outstanding (eoy) m22.72127.28 17.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.9 64.1%   
Avg P/E ratio x16.337.1 43.8%  
P/CF ratio (eoy) x15.929.6 53.9%  
Price / Book Value ratio x3.73.9 96.1%  
Dividend payout %29.722.0 135.2%   
Avg Mkt Cap Rs m21,15732,272 65.6%   
No. of employees `0000.51.1 45.5%   
Total wages/salary Rs m400661 60.5%   
Avg. sales/employee Rs Th13,787.46,132.2 224.8%   
Avg. wages/employee Rs Th813.0611.1 133.0%   
Avg. net profit/employee Rs Th2,643.3803.5 329.0%   
INCOME DATA
Net Sales Rs m6,7836,635 102.2%  
Other income Rs m353242 145.5%   
Total revenues Rs m7,1366,877 103.8%   
Gross profit Rs m1,6171,604 100.8%  
Depreciation Rs m27221 12.0%   
Interest Rs m638 14.6%   
Profit before tax Rs m1,9381,587 122.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632718 88.1%   
Profit after tax Rs m1,301869 149.6%  
Gross profit margin %23.824.2 98.6%  
Effective tax rate %32.645.2 72.1%   
Net profit margin %19.213.1 146.3%  
BALANCE SHEET DATA
Current assets Rs m6,9846,232 112.1%   
Current liabilities Rs m2,0561,490 138.0%   
Net working cap to sales %72.671.5 101.6%  
Current ratio x3.44.2 81.2%  
Inventory Days Days9986 114.8%  
Debtors Days Days2483 29.0%  
Net fixed assets Rs m2444,043 6.0%   
Share capital Rs m227127 178.5%   
"Free" reserves Rs m5,4418,183 66.5%   
Net worth Rs m5,6688,310 68.2%   
Long term debt Rs m2518 140.4%   
Total assets Rs m7,90110,389 76.1%  
Interest coverage x353.343.1 819.7%   
Debt to equity ratio x00 205.9%  
Sales to assets ratio x0.90.6 134.4%   
Return on assets %16.58.7 189.3%  
Return on equity %22.910.5 219.3%  
Return on capital %34.019.5 174.5%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m155,622 0.3%   
Fx outflow Rs m2,6771,799 148.8%   
Net fx Rs m-2,6623,822 -69.6%   
CASH FLOW
From Operations Rs m923356 259.7%  
From Investments Rs m317-279 -113.7%  
From Financial Activity Rs m-481-225 213.7%  
Net Cashflow Rs m759-148 -512.2%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 0.0 -  
FIIs % 7.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 36.5 83.3%  
Shareholders   21,978 37,287 58.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  DR. REDDYS LAB  GSK PHARMA  

Compare WYETH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Nosedived 1,939 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended deep in the red.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WYETH SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH

WYETH - ELDER PHARMA COMPARISON

COMPARE WYETH WITH

MARKET STATS